Dinh, J. C., Boone, E. C., Staggs, V. S., Pearce, R. E., Wang, W. Y., Gaedigk, R., . . . Gaedigk, A. (2022). The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity. Clinical pharmacology and therapeutics, 111(3), 646. https://doi.org/10.1002/cpt.2469
Citácia podle Chicago (17th ed.)Dinh, Jean C., Erin C. Boone, Vincent S. Staggs, Robin E. Pearce, Wendy Y. Wang, Roger Gaedigk, James Steven Leeder, a Andrea Gaedigk. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics 111, no. 3 (2022): 646. https://doi.org/10.1002/cpt.2469.
Citácia podľa MLA (8th ed.)Dinh, Jean C., et al. "The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity." Clinical Pharmacology and Therapeutics, vol. 111, no. 3, 2022, p. 646, https://doi.org/10.1002/cpt.2469.